Furosemide Tablets BP 40mg Malta - anglų - Medicines Authority

furosemide tablets bp 40mg

wockhardt uk limited - furosemide - tablet - furosemide 40 mg - diuretics

Apo-Furosemide Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

apo-furosemide

ipca pharma (nz) pty limited - furosemide 20mg - tablet - 20 mg - active: furosemide 20mg excipient: lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium starch glycolate - furosemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. furosemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.

FRUSEMIDE SANDOZ furosemide (frusemide) 40mg tablet bottle Australija - anglų - Department of Health (Therapeutic Goods Administration)

frusemide sandoz furosemide (frusemide) 40mg tablet bottle

sandoz pty ltd - furosemide, quantity: 40 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; maize starch; lactose monohydrate; magnesium stearate; sodium starch glycollate - oedema: adults. treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. frusemide sandoz is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. hypertension: adults. oral frusemide sandoz may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide sandoz alone.

APO-FUROSEMIDE TABLET Kanada - anglų - Health Canada

apo-furosemide tablet

apotex inc - furosemide - tablet - 40mg - furosemide 40mg - loop diuretics

APO-FUROSEMIDE TABLET Kanada - anglų - Health Canada

apo-furosemide tablet

apotex inc - furosemide - tablet - 20mg - furosemide 20mg - loop diuretics

APO-FUROSEMIDE TABLET Kanada - anglų - Health Canada

apo-furosemide tablet

apotex inc - furosemide - tablet - 80mg - furosemide 80mg - loop diuretics

FUROSEMIDE TABLET Kanada - anglų - Health Canada

furosemide tablet

sanis health inc - furosemide - tablet - 20mg - furosemide 20mg - loop diuretics

FUROSEMIDE TABLET Kanada - anglų - Health Canada

furosemide tablet

sanis health inc - furosemide - tablet - 40mg - furosemide 40mg - loop diuretics

FUROSEMIDE TABLET Kanada - anglų - Health Canada

furosemide tablet

sanis health inc - furosemide - tablet - 80mg - furosemide 80mg - loop diuretics

APO-FRUSEMIDE furosemide 20 mg tablet bottle Australija - anglų - Department of Health (Therapeutic Goods Administration)

apo-frusemide furosemide 20 mg tablet bottle

arrotex pharmaceuticals pty ltd - furosemide, quantity: 20 mg - tablet - excipient ingredients: pregelatinised maize starch; magnesium stearate; lactose monohydrate; sodium starch glycollate type a; maize starch - oedema frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. parenteral use should be replaced with oral frusemide as soon as practical.,hypertension oral frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.